During Brazil's COVID-19 vaccination campaign, when several brands of vaccines were available and the Chinese vaccine was the ...

AstraZeneca already has 19 R&D, manufacturing and commercial sites in the US, and the country is the company’s largest market, representing 42% of their revenue. The firm currently employs more ...

Following reports of an ex-AstraZeneca executive being detained in China, the company acknowledged that its current president in the country, Leon Wang, "is cooperating with an ongoing ...

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on Monday, the latest big investment by a pharmaceutical company reacting to ...

In 2015, Mexico and Canada successfully challenged U.S. country of origin labeling (COOL) requirements for pork and beef at the World Trade Organization.

Currently, the AstraZeneca COVID-19 vaccine has not been approved for emergency use in the United States. The U.S. is administering Pfizer and BioNTech’s two-dose shot and J&J’s one-dose shot.